Skip to main content

RETRACTION

Pathol. Oncol. Res., 28 March 2024

Retraction: MiR-184 retarded the proliferation, invasiveness and migration of glioblastoma cells by repressing stanniocalcin-2

A Retraction of the Original Article
MiR-184 retarded the proliferation, invasiveness and migration of glioblastoma cells by repressing stanniocalcin-2

by Feng L, Ma J, Ji H, Liu Y and Hu W (2018). Pathol. Oncol. Res. 24:853–860. doi: 10.1007/s12253-017-0298-z

Following publication, concerns were raised on the PubPeer platform regarding the validity of the data in the article. An investigation by the Editorial Office, conducted in accordance with Pathology and Oncology Research policies, was unable to confirm the validity of the data presented and as such cannot confirm its reliability. The article is therefore retracted.

This retraction was approved by the Editor-in-Chief of Pathology and Oncology Research. The authors received communication regarding the retraction but did not respond. The communication has been recorded by the publisher.

Pathology and Oncology Research would like to thank the concerned reader who contacted us regarding the published article.

Citation: Pathology & Oncology Research Editorial Office (2024) Retraction: MiR-184 retarded the proliferation, invasiveness and migration of glioblastoma cells by repressing stanniocalcin-2. Pathol. Oncol. Res. 30:1611767. doi: 10.3389/pore.2024.1611767

Received: 14 March 2024; Accepted: 14 March 2024;
Published: 28 March 2024.

Approved by:

József Tímár, Semmelweis University, Hungary

Copyright © 2024 Pathology & Oncology Research Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Pathology & Oncology Research Editorial Office, editorialoffice@por-journal.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.